NYSE:SOLVMedical Equipment
Solventum Expands MedSurg With Acera Deal As Valuation Signals Upside
Solventum (NYSE:SOLV) has completed its acquisition of Acera Surgical, a bioscience company focused on regenerative wound care.
The deal expands Solventum's MedSurg portfolio and adds exposure to regenerative medicine applications in US acute care settings.
The company expects the transaction to have a long term accretive impact.
For you as an investor, this move puts more attention on Solventum's MedSurg business, which already plays a central role in hospital and surgical settings...